DE68923556D1 - Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes. - Google Patents

Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes.

Info

Publication number
DE68923556D1
DE68923556D1 DE68923556T DE68923556T DE68923556D1 DE 68923556 D1 DE68923556 D1 DE 68923556D1 DE 68923556 T DE68923556 T DE 68923556T DE 68923556 T DE68923556 T DE 68923556T DE 68923556 D1 DE68923556 D1 DE 68923556D1
Authority
DE
Germany
Prior art keywords
acid
binding protein
insulin
protein
unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68923556T
Other languages
English (en)
Other versions
DE68923556T2 (de
Inventor
Robert Charles Baxter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Sydney Area Health Service
Original Assignee
Central Sydney Area Health Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Sydney Area Health Service filed Critical Central Sydney Area Health Service
Publication of DE68923556D1 publication Critical patent/DE68923556D1/de
Application granted granted Critical
Publication of DE68923556T2 publication Critical patent/DE68923556T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE68923556T 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes. Expired - Lifetime DE68923556T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPI931488 1988-07-15
AUPJ335089 1989-03-23
PCT/AU1989/000299 WO1990000569A1 (en) 1988-07-15 1989-07-14 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex

Publications (2)

Publication Number Publication Date
DE68923556D1 true DE68923556D1 (de) 1995-08-24
DE68923556T2 DE68923556T2 (de) 1996-04-11

Family

ID=25643507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923556T Expired - Lifetime DE68923556T2 (de) 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes.

Country Status (8)

Country Link
US (1) US5936064A (de)
EP (1) EP0424416B1 (de)
JP (4) JP3178714B2 (de)
AT (1) ATE125268T1 (de)
CA (1) CA1341598C (de)
DE (1) DE68923556T2 (de)
HK (1) HK206196A (de)
WO (1) WO1990000569A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222117T1 (de) * 1990-05-30 2002-08-15 Harvard College Kombination aus igf-i und tgf-beta zur knochenregenerierung
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
CA2090703A1 (en) * 1990-08-28 1992-03-01 Michael C. Kiefer Insulin-like growth factor binding protein (igfbp-4)
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
ATE247164T1 (de) * 1991-01-08 2003-08-15 Chiron Corp Insulinartigen wachstumsfaktor bindendes protein
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
DE69333063T2 (de) 1992-11-04 2004-05-13 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
JPH09500088A (ja) * 1993-01-29 1997-01-07 アムジェン ボールダー インコーポレイテッド 創傷治癒用組成物
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
AU715608B2 (en) * 1996-03-20 2000-02-03 Morphosys Ag Purification of tissue plasminogen activator (tPA)
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US7153691B2 (en) * 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
AU2003903896A0 (en) 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
WO2005033132A2 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
EP2507261B1 (de) 2009-11-30 2016-12-21 Factor Therapeutics Limited Fibronectin: wachstumsfaktoren-chimären

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627423B2 (en) * 1987-04-06 1992-08-27 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
JPH03504597A (ja) * 1988-04-12 1991-10-09 シナージェン，インコーポレーテッド インスリン様成長因子活性の強化および阻害方法
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5258257A (en) * 1991-09-23 1993-11-02 Shipley Company Inc. Radiation sensitive compositions comprising polymer having acid labile groups

Also Published As

Publication number Publication date
WO1990000569A1 (en) 1990-01-25
EP0424416B1 (de) 1995-07-19
JP2001252087A (ja) 2001-09-18
JP2005118052A (ja) 2005-05-12
JPH03506030A (ja) 1991-12-26
ATE125268T1 (de) 1995-08-15
JP3178714B2 (ja) 2001-06-25
DE68923556T2 (de) 1996-04-11
US5936064A (en) 1999-08-10
CA1341598C (en) 2009-09-29
HK206196A (en) 1996-11-22
EP0424416A4 (en) 1992-03-18
JP2003319791A (ja) 2003-11-11
EP0424416A1 (de) 1991-05-02

Similar Documents

Publication Publication Date Title
DE68923556D1 (de) Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes.
DE3851153D1 (de) Genetische modifizierung von endothelialen zellen.
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
LU91237I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance)
DK0423980T3 (da) Stamcellefaktor
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
ATE245437T1 (de) Wachstumsfaktor-b, spezifisch für vaskuläre endothelzellen
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
EP0575546A4 (en) Prad1 cyclin and its cdna
ATE423788T1 (de) Neues tgf-beta-ahnliches cytokin
EP0434713A4 (en) Hiv-1 envelope muteins lacking hypervariable domains
DE3650135D1 (de) Proteingewinnung.
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
BG60324B2 (en) New somatotropines
EP0336779A3 (de) Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
NZ503401A (en) Use of interferon-beta (IFN-B) genes for the treatment of cancer
DE58909328D1 (de) Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen HbA1c.
ES8600518A1 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
GB9401689D0 (en) Diagnosis and treatment of endocarditis
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
UA27048C2 (uk) Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату

Legal Events

Date Code Title Description
8364 No opposition during term of opposition